These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24831729)
21. Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening. Hopkins PN Curr Opin Lipidol; 2017 Apr; 28(2):136-143. PubMed ID: 28030379 [TBL] [Abstract][Full Text] [Related]
22. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies. Martin AC; Bell DA; Brett T; Watts GF Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524 [TBL] [Abstract][Full Text] [Related]
24. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635 [TBL] [Abstract][Full Text] [Related]
25. Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry. Gidding SS; Sheldon A; Neben CL; Williams HE; Law S; Zhou AY; Wilemon K; Ahmed CD; Kindt I J Clin Lipidol; 2020; 14(2):218-223.e2. PubMed ID: 32143996 [TBL] [Abstract][Full Text] [Related]
26. Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening. Baldry E; Redlinger-Grosse K; MacFarlane I; Walters ST; Ash E; Steinberger J; Murdy K; Cragun D; Allen-Tice C; Zierhut H J Genet Couns; 2022 Feb; 31(1):164-175. PubMed ID: 34260792 [TBL] [Abstract][Full Text] [Related]
27. Reducing the burden of disease and death from familial hypercholesterolemia: a call to action. Knowles JW; O'Brien EC; Greendale K; Wilemon K; Genest J; Sperling LS; Neal WA; Rader DJ; Khoury MJ Am Heart J; 2014 Dec; 168(6):807-11. PubMed ID: 25458642 [TBL] [Abstract][Full Text] [Related]
28. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. George R; Kovak K; Cox SL J Genet Couns; 2015 Jun; 24(3):388-99. PubMed ID: 25577298 [TBL] [Abstract][Full Text] [Related]
29. Identification of people with heterozygous familial hypercholesterolemia. Haase A; Goldberg AC Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386 [TBL] [Abstract][Full Text] [Related]
30. Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Marks D; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE; Ann Clin Biochem; 2009 Jan; 46(Pt 1):24-32. PubMed ID: 19028807 [TBL] [Abstract][Full Text] [Related]
31. A scoping review of interventions increasing screening and diagnosis of familial hypercholesterolemia. Polanski A; Wolin E; Kocher M; Zierhut H Genet Med; 2022 Sep; 24(9):1791-1802. PubMed ID: 35713652 [TBL] [Abstract][Full Text] [Related]
32. Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA. Miller DM; Gaviglio A; Zierhut HA Public Health Genomics; 2021; 24(3-4):110-122. PubMed ID: 33853081 [TBL] [Abstract][Full Text] [Related]
33. Detecting familial hypercholesterolaemia in general practice. Kirke A; Watts GF; Emery J Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121 [TBL] [Abstract][Full Text] [Related]
34. Advanced method for the identification of patients with inherited hypercholesterolemia. Defesche JC; Lansberg PJ; Umans-Eckenhausen MA; Kastelein JJ Semin Vasc Med; 2004 Feb; 4(1):59-65. PubMed ID: 15199434 [TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia. Ajufo E; deGoma EM; Raper A; Yu KD; Cuchel M; Rader DJ Genet Med; 2021 Sep; 23(9):1697-1704. PubMed ID: 34040191 [TBL] [Abstract][Full Text] [Related]
36. Medication adherence, cascade screening, and lifestyle patterns among women with hypercholesterolemia: Results from the WomenHeart survey. Benson G; Witt DR; VanWormer JJ; Campbell SM; Sillah A; Hayes SN; Lui M; Gulati M J Clin Lipidol; 2016; 10(4):937-943. PubMed ID: 27578126 [TBL] [Abstract][Full Text] [Related]
37. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Austin MA; Hutter CM; Zimmern RL; Humphries SE Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837 [TBL] [Abstract][Full Text] [Related]
38. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation. Bangash H; Makkawy A; Gundelach JH; Miller AA; Jacobson KA; Kullo IJ JMIR Hum Factors; 2022 Feb; 9(1):e32568. PubMed ID: 35166678 [TBL] [Abstract][Full Text] [Related]